Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Xtant Medical Holdings (XTNT) over the last 16 years, with Q3 2025 value amounting to $958000.0.

  • Xtant Medical Holdings' Change in Accured Expenses rose 33348.42% to $958000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 72476.42%. This contributed to the annual value of -$2.9 million for FY2024, which is 17695.35% down from last year.
  • Xtant Medical Holdings' Change in Accured Expenses amounted to $958000.0 in Q3 2025, which was up 33348.42% from $23000.0 recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Change in Accured Expenses ranged from a high of $2.7 million in Q1 2025 and a low of -$1.6 million during Q3 2021
  • Its 5-year average for Change in Accured Expenses is $243526.3, with a median of $221000.0 in 2024.
  • Per our database at Business Quant, Xtant Medical Holdings' Change in Accured Expenses surged by 1063636.36% in 2021 and then tumbled by 78877.55% in 2024.
  • Over the past 5 years, Xtant Medical Holdings' Change in Accured Expenses (Quarter) stood at $270000.0 in 2021, then surged by 75.93% to $475000.0 in 2022, then soared by 198.74% to $1.4 million in 2023, then tumbled by 175.55% to -$1.1 million in 2024, then surged by 189.37% to $958000.0 in 2025.
  • Its Change in Accured Expenses was $958000.0 in Q3 2025, compared to $23000.0 in Q2 2025 and $2.7 million in Q1 2025.